Bayer Mulls Helping CureVac Produce Its Covid-Vaccine: Welt

Bayer AG is mulling extending a cooperation agreement with CureVac NV to produce the German pharmaceutical company’s Covid-19 vaccine candidate, according to Welt am Sonntag.

Bayer is “examining intensively” if it can help produce CureVac’s vaccine, which isn’t covered by their existing cooperation agreement, the German pharma giant’s CEO, Werner Baumann, said in an interview with the newspaper. “With our production network in Germany and the U.S. and appropriate lead time, we would in principle be able to produce larger amounts of vaccine,” he said.

Bayer is ready to “pull out all the stops” to make the vaccine available ...